(Inclusive of all Taxes)
Get Free delivery (₹99)
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
संघटन :
ब्रोमोक्रिप्टाइन-1.25एमजी
निर्माता/विपणक :
ग्लैक्सो स्मिथक्लाइन फार्मास्यूटिकल्स लिमिटेड
उपभोग प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
को या उसके बाद समाप्त हो जाएगा :
Jan-27
Have a query?
Drug-Drug Interactions
BromocriptineErgotamine
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
BromocriptineErgotamine
Critical
How does the drug interact with Sicriptin 1.25 Tablet:
When these medications are taken combined, they can have an additive effect, causing severe constriction of blood vessels and decreased blood flow to the vital organs, which increases the risk of side effects.
How to manage the interaction:
Co-administration of Sicriptin 1.25 Tablet with Ergotamine can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away. These symptoms include pain in chest, severe stomach pain, feeling sick, numbness or tingling, muscle pain or weakness, fingers or toes turning blue or purple, pale or cold skin, chest pain, irregular heartbeat, intense headache, difficulty breathing, blurry vision, confusion, or trouble speaking clearly. Do not discontinue any medications without first consulting your doctor.
When these medications are taken combined, they can have an additive effect, causing severe constriction of blood vessels and decreased blood flow to the vital organs, which increases the risk of side effects.
How to manage the interaction:
Co-administration of Sicriptin 1.25 Tablet with Ergotamine can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away. These symptoms include pain in chest, severe stomach pain, feeling sick, numbness or tingling, muscle pain or weakness, fingers or toes turning blue or purple, pale or cold skin, chest pain, irregular heartbeat, intense headache, difficulty breathing, blurry vision, confusion, or trouble speaking clearly. Do not discontinue any medications without first consulting your doctor.
Critical
How does the drug interact with Sicriptin 1.25 Tablet:
Sicriptin 1.25 Tablet can make Almotriptan more effective at narrowing blood vessels, reducing blood flow to vital organs.
How to manage the interaction:
Taking Sicriptin 1.25 Tablet with Almotriptan together results in an interaction, but they can be taken together if advised by your doctor. However, contact your doctor if you experience abdominal pain, numbness or tingling, muscle pain or weakness, or headache. Do not stop taking any medications without consulting a doctor.
Sicriptin 1.25 Tablet can make Almotriptan more effective at narrowing blood vessels, reducing blood flow to vital organs.
How to manage the interaction:
Taking Sicriptin 1.25 Tablet with Almotriptan together results in an interaction, but they can be taken together if advised by your doctor. However, contact your doctor if you experience abdominal pain, numbness or tingling, muscle pain or weakness, or headache. Do not stop taking any medications without consulting a doctor.
BromocriptineNaratriptan
Critical
How does the drug interact with Sicriptin 1.25 Tablet:
Taking Sicriptin 1.25 Tablet with Naratriptan can increase the risk of side effects such as high blood pressure and heart-related problems.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet and Naratriptan, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience abdominal pain, nausea, vomiting, numbness or tingling, muscle pain or weakness, blue or purple discoloration of fingers or toes, pale or cold skin, or chest pain. Do not discontinue any medications without consulting a doctor.
Taking Sicriptin 1.25 Tablet with Naratriptan can increase the risk of side effects such as high blood pressure and heart-related problems.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet and Naratriptan, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience abdominal pain, nausea, vomiting, numbness or tingling, muscle pain or weakness, blue or purple discoloration of fingers or toes, pale or cold skin, or chest pain. Do not discontinue any medications without consulting a doctor.
Critical
How does the drug interact with Sicriptin 1.25 Tablet:
Taking eletriptan with Sicriptin 1.25 Tablet can increase the risk of side effects such as high blood pressure and heart-related problems.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet with eletriptan, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience abdominal pain, nausea, vomiting, numbness or tingling, muscle pain or weakness, blue or purple discoloration of fingers or toes, pale or cold skin, or chest pain. Do not discontinue any medications without consulting a doctor.
Taking eletriptan with Sicriptin 1.25 Tablet can increase the risk of side effects such as high blood pressure and heart-related problems.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet with eletriptan, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience abdominal pain, nausea, vomiting, numbness or tingling, muscle pain or weakness, blue or purple discoloration of fingers or toes, pale or cold skin, or chest pain. Do not discontinue any medications without consulting a doctor.
Critical
How does the drug interact with Sicriptin 1.25 Tablet:
Coadministration of Sicriptin 1.25 Tablet with rizatriptan can increase the risk of side effects such as high blood pressure and heart-related problems.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet and rizatriptan, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience abdominal pain, nausea, vomiting, numbness or tingling, muscle pain or weakness, blue or purple discoloration of fingers or toes, pale or cold skin, chest pain or tightness. Do not discontinue any medications without consulting a doctor.
Coadministration of Sicriptin 1.25 Tablet with rizatriptan can increase the risk of side effects such as high blood pressure and heart-related problems.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet and rizatriptan, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience abdominal pain, nausea, vomiting, numbness or tingling, muscle pain or weakness, blue or purple discoloration of fingers or toes, pale or cold skin, chest pain or tightness. Do not discontinue any medications without consulting a doctor.
Critical
How does the drug interact with Sicriptin 1.25 Tablet:
Coadministration of Sicriptin 1.25 Tablet with Sumatriptan can increase the risk or severity of side effects like high blood pressure or heart-related disorders.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet and Sumatriptan, they can be taken together if prescribed by a doctor. However, if you experience abdominal pain, nausea, vomiting, numbness or tingling, muscle pain or weakness, blue or purple discoloration of fingers or toes, pale or cold skin, chest pain or tightness, irregular heartbeat, severe headache, shortness of breath, blurred vision, confusion, consult a doctor. Do not discontinue any medication without consulting a doctor.
Coadministration of Sicriptin 1.25 Tablet with Sumatriptan can increase the risk or severity of side effects like high blood pressure or heart-related disorders.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet and Sumatriptan, they can be taken together if prescribed by a doctor. However, if you experience abdominal pain, nausea, vomiting, numbness or tingling, muscle pain or weakness, blue or purple discoloration of fingers or toes, pale or cold skin, chest pain or tightness, irregular heartbeat, severe headache, shortness of breath, blurred vision, confusion, consult a doctor. Do not discontinue any medication without consulting a doctor.
How does the drug interact with Sicriptin 1.25 Tablet:
Coadministration of Sicriptin 1.25 Tablet with itraconazole may significantly increase the blood levels of Sicriptin 1.25 Tablet.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet and itraconazole, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience headache, dizziness, drowsiness, or lightheadedness. Do not discontinue any medications without consulting a doctor.
Coadministration of Sicriptin 1.25 Tablet with itraconazole may significantly increase the blood levels of Sicriptin 1.25 Tablet.
How to manage the interaction:
Although there is an interaction between Sicriptin 1.25 Tablet and itraconazole, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience headache, dizziness, drowsiness, or lightheadedness. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Sicriptin 1.25 Tablet:
Crizotinib may considerably raise the blood levels of Sicriptin 1.25 Tablet. This may enhance the risk of adverse effects of Sicriptin 1.25 Tablet.
How to manage the interaction:
Although taking Sicriptin 1.25 Tablet and Crizotinib together can cause an interaction, it can be taken if your doctor has suggested it. Call your doctor immediately if you notice any of these symptoms - feeling dizzy or tired, suddenly falling asleep, or feeling lightheaded. Do not stop using any medications without talking to your doctor.
Crizotinib may considerably raise the blood levels of Sicriptin 1.25 Tablet. This may enhance the risk of adverse effects of Sicriptin 1.25 Tablet.
How to manage the interaction:
Although taking Sicriptin 1.25 Tablet and Crizotinib together can cause an interaction, it can be taken if your doctor has suggested it. Call your doctor immediately if you notice any of these symptoms - feeling dizzy or tired, suddenly falling asleep, or feeling lightheaded. Do not stop using any medications without talking to your doctor.
Severe
How does the drug interact with Sicriptin 1.25 Tablet:
Taking Clozapine with Sicriptin 1.25 Tablet may increase the risk of side effects.
How to manage the interaction:
There may be a possibility of interaction between Sicriptin 1.25 Tablet and Clozapine, but it can be taken if prescribed by a doctor. Contact a doctor immediately if you feel sleepy, dizzy, or lightheaded. Avoid driving or operating hazardous machinery, use caution when getting up from a sitting or lying position, and do not discontinue any medications without consulting a doctor.
Taking Clozapine with Sicriptin 1.25 Tablet may increase the risk of side effects.
How to manage the interaction:
There may be a possibility of interaction between Sicriptin 1.25 Tablet and Clozapine, but it can be taken if prescribed by a doctor. Contact a doctor immediately if you feel sleepy, dizzy, or lightheaded. Avoid driving or operating hazardous machinery, use caution when getting up from a sitting or lying position, and do not discontinue any medications without consulting a doctor.
BromocriptineAmprenavir
Severe
How does the drug interact with Sicriptin 1.25 Tablet:
Sicriptin 1.25 Tablet can increase the levels of Axitinib in your blood. This may raise the risk of side effects.
How to manage the interaction:
There may be a possibility of interaction between Sicriptin 1.25 Tablet and Amprenavir, but it can be taken if prescribed by a doctor. If you experience a headache or feel dizzy or drowsy, consult a doctor immediately. Do not stop using any medications without consulting your doctor.
Sicriptin 1.25 Tablet can increase the levels of Axitinib in your blood. This may raise the risk of side effects.
How to manage the interaction:
There may be a possibility of interaction between Sicriptin 1.25 Tablet and Amprenavir, but it can be taken if prescribed by a doctor. If you experience a headache or feel dizzy or drowsy, consult a doctor immediately. Do not stop using any medications without consulting your doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
शराब
Unsafe
सिक्रिप्टिन 1.25 टैबलेट 10's को चक्कर आने का कारण माना जाता है। इसलिए, सिक्रिप्टिन 1.25 टैबलेट 10's के साथ शराब का सेवन नहीं करना चाहिए।
गर्भावस्था
Caution
सिक्रिप्टिन 1.25 टैबलेट 10's एक श्रेणी बी गर्भावस्था दवा है और गर्भवती महिला को केवल तभी दी जाती है जब डॉक्टर को लगता है कि लाभ जोखिम से अधिक है। हालाँकि, उच्च रक्तचाप वाली गर्भवती महिलाओं को इसकी सलाह नहीं दी जाती है क्योंकि यह खतरनाक हो सकती है।
स्तनपान
Unsafe
सिक्रिप्टिन 1.25 टैबलेट 10's आपके बच्चे के लिए दूध का उत्पादन बंद कर देगा, यदि आप स्तनपान कराने की योजना बना रही हैं तो आपको यह दवा नहीं लेनी चाहिए।
ड्राइविंग
Caution
सिक्रिप्टिन 1.25 टैबलेट 10's चक्कर आने का कारण माना जाता है। इसलिए, ड्राइविंग या कोई भी मशीनरी जिसमें एकाग्रता की आवश्यकता होती है, उससे बचना चाहिए।
जिगर
Caution
सिक्रिप्टिन 1.25 टैबलेट 10's सावधानी के साथ लिया जाना चाहिए, खासकर अगर आपको लिवर की बीमारियों/स्थितियों का इतिहास है। खुराक को आपके डॉक्टर द्वारा समायोजित किया जाना पड़ सकता है।
किडनी
Caution
सिक्रिप्टिन 1.25 टैबलेट 10's सावधानी के साथ लिया जाना चाहिए, खासकर अगर आपको किडनी की बीमारियों/स्थितियों का इतिहास है। खुराक को आपके डॉक्टर द्वारा समायोजित किया जाना पड़ सकता है।
बच्चे
Caution
सिक्रिप्टिन 1.25 टैबलेट 10's का इस्तेमाल 16 साल से कम उम्र की महिलाओं में नहीं किया जाना चाहिए। यह घातक हो सकता है।
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
